RAVICTI

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug RAVICTI contains one active pharmaceutical ingredient (API):

1	Glycerol phenylbutyrate UNII ZH6F1VCV7B - GLYCEROL PHENYLBUTYRATE
	Glycerol phenylbutyrate is a nitrogen-binding medicinal product. Urea cycle disorders (UCDs) are inherited deficiencies of enzymes or transporters necessary for the synthesis of urea from ammonia (NH3, NH4+). Absence of these enzymes or transporters results in the accumulation of toxic levels of ammonia in the blood and brain of affected patients. Glycerol phenylbutyrate is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (UCDs).
	Read more about Glycerol phenylbutyrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RAVICTI Oral liquid	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AX09		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AX Various alimentary tract and metabolism products
Discover more medicines within A16AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02453304
EE	Ravimiamet	1706093
ES	Centro de información online de medicamentos de la AEMPS	1151062001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	452031
FR	Base de données publique des médicaments	60150015
GB	Medicines & Healthcare Products Regulatory Agency	346104
IE	Health Products Regulatory Authority	88894
IL	מִשְׂרַד הַבְּרִיאוּת	8691
IT	Agenzia del Farmaco	044568018, 044568020, 044568032, 044568044
LT	Valstybinė vaistų kontrolės tarnyba	1079123
NL	Z-Index G-Standaard, PRK	150126
PL	Rejestru Produktów Leczniczych	100362119
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66621001, W66621002, W66621003, W66621004
US	FDA, National Drug Code	75987-050